CASI Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.46
|
-0.38
|
0.08
|
17.39%
|
|
2022-06-30
|
-0.64
|
-0.56
|
0.08
|
12.50%
|
|
2022-03-31
|
-0.87
|
-0.60
|
0.27
|
31.03%
|
|
2021-12-31
|
-0.57
|
-0.40
|
0.17
|
29.82%
|
|
2021-09-30
|
-0.55
|
-0.70
|
-0.15
|
-27.27%
|
|
2021-06-30
|
-0.72
|
-0.50
|
0.22
|
30.56%
|
|
2021-03-31
|
-0.60
|
-1.10
|
-0.50
|
-83.33%
|
|
2020-12-31
|
-0.70
|
-1.20
|
-0.50
|
-71.43%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.54
|
|
2021-12-31
|
-2.70
|
|
2020-12-31
|
-3.59
|
|
2019-12-31
|
-0.47
|
|
2018-12-31
|
-0.32
|
|
2017-12-31
|
-0.18
|
|
2016-12-31
|
-0.20
|
|
2015-12-31
|
-0.22
|
|
2014-12-31
|
-1.42
|
|
2013-12-31
|
-2.19
|
|
2012-12-31
|
-8.54
|
|
2011-12-31
|
-4.81
|
|
2010-12-31
|
-10.63
|
|
2009-12-31
|
-12.37
|
|
2008-12-31
|
-17.68
|
|
2007-12-31
|
-3.08
|
|
2006-12-31
|
-8.25
|
|
2005-12-31
|
-3.96
|
|
2004-12-31
|
-13.17
|
|
2003-12-31
|
-42.60
|
|
2002-12-31
|
-19.69
|
|
2001-12-31
|
-26.40
|
|
2000-12-31
|
-33.44
|
|
1999-12-31
|
-29.15
|
|
1998-12-31
|
-11.66
|
|
1997-12-31
|
-5.94
|
|
1996-12-31
|
-2.31
|